Schonfeld Strategic Advisors LLC Invests $327,000 in Aclaris Therapeutics, Inc. (NASDAQ:ACRS)
Schonfeld Strategic Advisors LLC acquired a new stake in shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 131,895 shares of the biotechnology company’s stock, valued at approximately $327,000. A number of other hedge […]
Schonfeld Strategic Advisors LLC acquired a new stake in shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 131,895 shares of the biotechnology company’s stock, valued at approximately $327,000. A number of other hedge […]
